Leucadia National - ERYTECH PHARMA ownership

Quarter-by-quarter ownership
Leucadia National ownership history of ERYTECH PHARMA
ValueSharesWeighting
Q4 2022$189,048572,6980.00%
Other shareholders
ERYTECH PHARMA shareholders Q3 2023
NameSharesValueWeighting ↓
StoneX Group Inc. 17,304$130.00%
Baader Bank Aktiengesellschaft 24,000$14,7160.00%
Vanguard Personalized Indexing Management, LLC 24,271$18,6890.00%
Citadel Advisors 400$2920.00%
Citadel Advisors 16,606$12,1220.00%
Asset Dedication, LLC 4,000$30.00%
Ikarian Capital, LLC 3,019$2,2570.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 10,590$7,7310.00%
MILLENNIUM MANAGEMENT LLC 12,069$8,8100.00%
View complete list of ERYTECH PHARMA shareholders